Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Macbeth

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2001
Radiation myelitis and thoracic radiotherapy: evidence and anecdoteF Macbeth
BMJ (Clinical Research Ed.)|July 15, 2000
Managing patients with lung cancer. All evidence was considered when COIN guidelines were drawn upF Macbeth
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 30, 2010
Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidenceN O'Rourke, F Macbeth
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Non-small cell lung cancer: are we out of step?A Gregor, F Macbeth
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 31, 2015
Metastasectomy for SarcomaF Macbeth, T Treasure
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 22, 2016
Stereotactic Ablative Radiotherapy for 'Oligometastases': a Treatment in Search of EvidenceF Macbeth, T Treasure
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 17, 2020
Local treatment of 'Oligometastases': Wishful thinking is not supported by available evidenceF Macbeth, T Treasure
International Journal of Radiation Oncology, Biology, Physics|July 1, 1994
Regarding "Longer survival and higher doses of thoracic radiotherapy in patients with limited non-small lung cancer"F Macbeth, A Gregor
Thorax|September 1, 1995
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancerR Milroy, F Macbeth
Lancet (London, England)|July 13, 1996
Marketing clinical trialsF Macbeth, R Stephens
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2001
Radiation myelitis and thoracic radiotherapy: evidence and anecdoteF Macbeth
BMJ (Clinical Research Ed.)|July 15, 2000
Managing patients with lung cancer. All evidence was considered when COIN guidelines were drawn upF Macbeth
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 30, 2010
Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidenceN O'Rourke, F Macbeth
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Non-small cell lung cancer: are we out of step?A Gregor, F Macbeth
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 31, 2015
Metastasectomy for SarcomaF Macbeth, T Treasure
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 22, 2016
Stereotactic Ablative Radiotherapy for 'Oligometastases': a Treatment in Search of EvidenceF Macbeth, T Treasure
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 17, 2020
Local treatment of 'Oligometastases': Wishful thinking is not supported by available evidenceF Macbeth, T Treasure
International Journal of Radiation Oncology, Biology, Physics|July 1, 1994
Regarding "Longer survival and higher doses of thoracic radiotherapy in patients with limited non-small lung cancer"F Macbeth, A Gregor
Thorax|September 1, 1995
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancerR Milroy, F Macbeth
Lancet (London, England)|July 13, 1996
Marketing clinical trialsF Macbeth, R Stephens
Pageof 6